Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Escape Bio
AddedFeb 15, 2024
UpdatedJun 18, 2026
Escape Bio

Escape Bio

Series D

ESCAPE Bio: A preclinical biopharmaceutical company developing therapies for neurodegenerative diseases.

HQ
South San Francisco, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to address genetically defined neurodegenerative diseases, ESCAPE Bio is a preclinical stage biopharmaceutical company. The organization is dedicated to discovering and developing innovative therapies aimed at treating central nervous system (CNS) disorders. By focusing on genetic underpinnings, ESCAPE Bio aims to make a significant clinical impact for patients suffering from these debilitating conditions.

Notable figures associated with ESCAPE Bio include experienced scientists and industry leaders in the field of neurodegeneration. The company has garnered attention and support from prominent investors in the biotech sector. Key achievements include advancing multiple therapeutic candidates through preclinical development stages, positioning the company as a promising player in the fight against CNS diseases. ESCAPE Bio's work holds the potential to transform treatment paradigms and improve patient outcomes significantly.

Escape Bio - Similar Companies

Denali Therapeutics logo

Denali Therapeutics

CuraSen Therapeutics logo

CuraSen Therapeutics

curasen.com

Convalesce logo

Convalesce

convalesce.co

Engrail Therapeutics logo

Engrail Therapeutics

engrail.com

Capsida Biotherapeutics logo

Capsida Biotherapeutics

capsida.com

Novoron Bioscience logo

Novoron Bioscience

novoron.com

Chase Therapeutics logo

Chase Therapeutics

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

Spinogenix logo

Spinogenix

spinogenix.com

Enterin logo

Enterin

enterininc.com

Apic Bio logo

Apic Bio

Faze Medicines logo

Faze Medicines

fazemed.com

Therini Bio logo

Therini Bio

therinibio.com

Amplifica logo

Amplifica

amplificabio.com

VistaGen Therapeutics logo

VistaGen Therapeutics

Escape Bio - Quick Facts

Who are Escape Bio's competitors?

Companies similar to Escape Bio include Denali Therapeutics, CuraSen Therapeutics, Convalesce and Engrail Therapeutics.

When was Escape Bio founded?

Escape Bio was founded in 2015.

Where is Escape Bio's headquarters located?

Escape Bio's headquarters is located in South San Francisco, CA, US.

When was Escape Bio's last funding round?

Escape Bio's most recent funding round was for $73M (USD) in September 2020.

How much has Escape Bio raised to-date?

As of Sep 14, 2020, Escape Bio has raised a total of $187.1M (USD).

How many employees does Escape Bio have?

Escape Bio has 39 employees as of Feb 5, 2024.

Escape Bio - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified